ENTRY       D01213                      Drug
NAME        Tolvaptan (JAN/USAN/INN);
            Samsca (TN)
PRODUCT     JYNARQUE (Otsuka America Pharmaceutical)
            SAMSCA (Otsuka America Pharmaceutical)
  GENERIC   TOLVAPTAN (Apotex Corp.)
            TOLVAPTAN (Apotex Corp.)
            TOLVAPTAN (Ascend Laboratories)
            TOLVAPTAN (Camber Pharmaceuticals)
            TOLVAPTAN (Novadoz Pharmaceuticals LLC)
            TOLVAPTAN (Par Pharmaceutical)
FORMULA     C26H25ClN2O3
EXACT_MASS  448.1554
MOL_WEIGHT  448.9413
CLASS       Cardiovascular agent
             DG01506  Arginine vasopressin receptor 2 (AVPR2) antagonist
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
            Transporter substrate
             DG01665  ABCB1 substrate
            Transporter inhibitor
             DG01622  ABCB1 inhibitor
REMARK      Therapeutic category: 2139 2499
            ATC code: C03XA01
            Chemical structure group: DG03074
            Product (DG03074): D01213<JP/US> D11659<JP>
EFFICACY    Diuretic, Vasopressin V2 receptor antagonist
COMMENT     Treatment of congestive heart failure and hyponatremia
TARGET      AVPR2 [HSA:554] [KO:K04228]
  PATHWAY   hsa04080(554)  Neuroactive ligand-receptor interaction
            hsa04962(554)  Vasopressin-regulated water reabsorption
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
            Transporter: ABCB1 [HSA:5243]
INTERACTION Transporter inhibition: ABCB1 [HSA:5243]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C03 DIURETICS
               C03X OTHER DIURETICS
                C03XA Vasopressin antagonists
                 C03XA01 Tolvaptan
                  D01213  Tolvaptan (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Electrolytes/Minerals/Metals/Vitamins
              Electrolyte/Mineral/Metal Modifiers
               Tolvaptan
                D01213  Tolvaptan (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               213  Diuretics
                2139  Others
                 D01213  Tolvaptan (JAN/USAN/INN)
              24  Hormones
               249  Miscellaneous
                2499  Others
                 D01213  Tolvaptan (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01506  Arginine vasopressin receptor 2 (AVPR2) antagonist
               DG03074  Tolvaptan
                D01213  Tolvaptan
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D01213  Tolvaptan
             Transporter substrate
              DG01665  ABCB1 substrate
               D01213  Tolvaptan
             Transporter inhibitor
              DG01622  ABCB1 inhibitor
               D01213  Tolvaptan
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Vasopressin
                AVPR2
                 D01213  Tolvaptan (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D01213
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D01213
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D01213
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D01213
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D01213
             Drug transporters
              D01213
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01506  Arginine vasopressin receptor 2 (AVPR2) antagonist
               DG03074  Tolvaptan
DBLINKS     CAS: 150683-30-0
            PubChem: 7848276
            ChEBI: 32246
            LigandBox: D01213
ATOM        32
            1   C1x C    11.2700   -8.8200
            2   C1x C    10.4300   -7.7000
            3   C1x C    10.7800   -6.3700
            4   C1y C    12.0400   -5.8100
            5   N1y N    12.6700   -8.8200
            6   C8y C    13.3000   -6.4400
            7   C8y C    13.5800   -7.7700
            8   C8x C    14.9100   -8.1900
            9   C8x C    15.9600   -7.2800
            10  C8y C    15.6800   -5.8800
            11  C8x C    14.3500   -5.4600
            12  O1a O    12.0400   -4.4100
            13  X   Cl   16.7222   -4.9452
            14  O5a O    12.6700  -11.2449
            15  C5a C    13.3700  -10.0324
            16  C8y C    14.7698  -10.0324
            17  C8y C    15.4603  -11.2280
            18  C8x C    16.8603  -11.2278
            19  C8y C    17.5601  -10.0153
            20  C8x C    16.8697   -8.8198
            21  C8x C    15.4697   -8.8199
            22  C1a C    14.7749  -12.4152
            23  N1b N    18.9700  -10.0152
            24  C5a C    19.6721   -8.7988
            25  C8y C    21.0698   -8.7987
            26  O5a O    18.9805   -7.6015
            27  C8y C    21.7793  -10.0270
            28  C8x C    23.1793  -10.0268
            29  C8x C    23.8791   -8.8142
            30  C8x C    23.1696   -7.5859
            31  C8x C    21.7696   -7.5861
            32  C1a C    21.0845  -11.2307
BOND        35
            1     3   4 1
            2     1   5 1
            3     4   6 1
            4     2   3 1
            5     5   7 1
            6     1   2 1
            7     6   7 1
            8     7   8 2
            9     8   9 1
            10    9  10 2
            11   10  11 1
            12    6  11 2
            13    4  12 1 #Up
            14   10  13 1
            15   14  15 2
            16    5  15 1
            17   15  16 1
            18   16  17 2
            19   17  18 1
            20   18  19 2
            21   19  20 1
            22   20  21 2
            23   16  21 1
            24   17  22 1
            25   19  23 1
            26   23  24 1
            27   24  25 1
            28   24  26 2
            29   25  27 2
            30   27  28 1
            31   28  29 2
            32   29  30 1
            33   30  31 2
            34   25  31 1
            35   27  32 1
///
